Stock listing
UTHR Stock Price, News, Filings & Events — United Therapeutics Corporation
Selected listing: UTHR · BIVA · MXN · MX
This page tracks United Therapeutics Corporation's UTHR:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UTHR:BIVA. UTHR:BIVA is the stock-level entry point for investors researching United Therapeutics Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. United Therapeutics Corporation, traded under the ticker UTHR, is a public company based in the United States with a market capitalization of approximately $22.43 billion. The company focuses on innovative therapies for the treatment of chronic and life-threatening conditions. United Therapeutics is committed to advancing healthcare solutions and improving patient outcomes through its research and development efforts.
- Ticker
- UTHR:BIVA
- Asset type
- Stock
- Market cap
- $22.11B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BIVA
- Currency
- MXN
United Therapeutics Corporation UTHR:BIVA stock context
This page tracks United Therapeutics Corporation's UTHR:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UTHR:BIVA. UTHR:BIVA is the stock-level entry point for investors researching United Therapeutics Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. United Therapeutics Corporation, traded under the ticker UTHR, is a public company based in the United States with a market capitalization of approximately $22.43 billion. The company focuses on innovative therapies for the treatment of chronic and life-threatening conditions. United Therapeutics is committed to advancing healthcare solutions and improving patient outcomes through its research and development efforts.
Latest news from United Therapeutics Corporation
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
September 1, 2026
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International ...
August 28, 2026
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hyperte...
August 24, 2026
United Therapeutics Corporation Reports Second Quarter 2026 Financial Results
August 5, 2026
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across met...
July 31, 2026
United Therapeutics Corporation earnings calls
United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call
October 29, 2025 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call
July 30, 2025 · Replay with transcript and chapters
United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call
April 30, 2025 · Replay with transcript and chapters
Research United Therapeutics Corporation
United Therapeutics Corporation investor report
Review AI stock analysis and investor report context for UTHR:BIVA.
United Therapeutics Corporation company profile
View the public company page for United Therapeutics Corporation on 6ix.
United Therapeutics Corporation news
Read company news and market updates connected to United Therapeutics Corporation.
United Therapeutics Corporation investor events
Find investor webinars, events, and replay context for United Therapeutics Corporation.
Alternate listings
UTHR:NASDAQ
US · USD
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTH:GETTEX
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
923818:LSX
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
923818:LS
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTHR:BMV
MX · MXN
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTH:TRADEGATE
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
U2TH34:BMFBOVESPA
BR · BRL
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTH:FWB
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTH:MUN
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTHR:BOATS
US · USD
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTH:BX
CH · CHF
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.
UTH:DUS
DE · EUR
Alternate listing for United Therapeutics Corporation; the primary context on this page is UTHR:BIVA.